$5.09
0.08[1.60%]
At close: Apr 30
$5.09
0[0.00%]
After Hours: 4:20PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/05/2024 | AUPH | Aurinia Pharmaceuticals | FY | 2023 | — | — | — | $176.00M | $176.00M | $174.71M | Get Alert |
01/05/2024 | AUPH | Aurinia Pharmaceuticals | Q4 | 2023 | — | — | — | $45.00M | $45.00M | $44.20M | Get Alert |
11/02/2023 | AUPH | Aurinia Pharmaceuticals | FY | 2023 | — | — | — | $155.00M | $160.00M | $161.65M | Get Alert |
08/03/2023 | AUPH | Aurinia Pharmaceuticals | FY | 2023 | — | — | — | $150.00M | $160.00M | $154.35M | Get Alert |
05/04/2023 | AUPH | Aurinia Pharmaceuticals | FY | 2023 | — | — | — | $135.00M | $155.00M | $142.68M | Get Alert |
01/06/2023 | AUPH | Aurinia Pharmaceuticals | FY | 2022 | — | — | — | $134.00M | $134.00M | $132.68M | Get Alert |
01/06/2023 | AUPH | Aurinia Pharmaceuticals | Q4 | 2022 | — | — | — | $28.40M | $28.40M | $26.97M | Get Alert |
There have been no specific sales or earnings guidance reported for Aurinia Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.